Epidermal receptor activator of NF-κB ligand controls Langerhans cells numbers and proliferation

Journal of Immunology

Volumn 181, Issue 2, 2008, Pages 1103-1108

  Barbaroux, Jean Baptiste O ^a,f   Beleut, Manfred ^b   Brisken, Cathrin ^b,c   Mueller, Christopher G ^d   Groves, Richard W ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b EPFL   (Switzerland)

^c Frontiers in Genetics National Center of Competence in Research   (Switzerland)

^d INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EPIDERMIS CELL; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; CELL COUNT; CYTOLOGY; EPIDERMIS; HUMAN; IMMUNOLOGY; KERATINOCYTE; METABOLISM; SIGNAL TRANSDUCTION;

CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; EPIDERMIS; HUMANS; KERATINOCYTES; LANGERHANS CELLS; NF-KAPPA B; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION;

EID: 49049091428     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.2.1103     Document Type: Article

References (39)

1. Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, and J. Davoust. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of birbeck granules. Immunity 12: 71-81. (Pubitemid 30069216)
2. Tang, A., M. Amagai, L. G. Granger, J. R. Stanley, and M. C. Udey. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361: 82-85. (Pubitemid 23020779)
3. Ginhoux, F., F. Tacke, V. Angeli, M. Bogunovic, M. Loubeau, X. M. Dai, E. R. Stanley, G. J. Randolph, and M. Merad. 2006. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7: 265-273.
4. Anderson, D. M., E. Maraskovsky, W. L. Billingsley, W. C. Dougall, M. E. Tometsko, E. R. Roux, M. C. Teepe, R. F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179.
5. Josien, R., B. R. Wong, H. L. Li, R. M. Steinman, and Y. Choi. 1999. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J. Immunol. 162: 2562-2568. (Pubitemid 29309274)
6. Wong, B. R., R. Josien, S. Y. Lee, B. Sauter, H. L. Li, R. M. Steinman, and Y. Choi. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186: 2075-2080.
7. Cremer, I., M. C. Dieu-Nosjean, S. Maréchal, C. Dezutter-Dambuyant, S. Goddard, D. Adams, N. Winetr, C. Menetrier-Caux, C. Sautès-Fridman, W. H. Fridman, and C. G. Mueller. 2002. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood 100: 3646-3655.
8. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323. (Pubitemid 29061638)
9. Dougall, W. C., M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, T. De Smedt, E. Daro, J. Smith, M. E. Tometsko, C. R. Maliszewski, et al. 1999. RANK is essential for osteoclast and lymph node development. Genes Dev. 13: 2412-2424.
10. Loser, K., A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J. M. Penninger, and S. Beissert. 2007. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12: 1372-1379. (Pubitemid 44924495)
11. Bachmann, M. F., B. R. Wong, R. Josien, R. M. Steinman, A. Oxenius, and Y. Choi. 1999. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 189: 1025-1031.
12. Fata, J. E., Y. Y. Kong, J. Li, T. Sasaki, J. Irie-Sasaki, R. A. Moorehead, R. Elliott, S. Scully, E. B. Voura, and D. L. Lacey. 2000. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103: 41-50.
13. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M.-S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, and T. Boone. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
14. Bucay, N., I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. L. Tan, W. Xu, D. L. Lacey, et al. 1998. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12: 1260-1268. (Pubitemid 28213402)
15. Josien, R., H. L. Li, E. Ingulli, S. Sarma, B. Wong, M. Vologodskaia, R. M. Steinman, and Y. Choi. 2000. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 3: 495-501. (Pubitemid 30693574)
16. Wong, B., R. Josien, and Y. Choi. 1999. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. J. Leukocyte Biol. 65: 715-724. (Pubitemid 29279518)
17. Kim, N. S., H. J. Kim, B. K. Koo, M. C. Kwon, Y. W. Kim, Y. Cho, Y. Yokota, J. M. Penninger, and Y. Y. Kong. 2006. Receptor activator of NF-κB ligand regulates the proliferation of mammary epithelial cells via Id2. Mol. Cell. Biol. 26: 1002-1013.
18. Lee, H. W., B. S. Kim, H. J. Kim, C. W. Lee, H. J. Yoo, J. B. Kim, and S. Yoon. 2005. Upregulation of receptor activator of nuclear factor-κB ligand expression in the thymic subcapsular, paraseptal, perivascular, and medullary epithelial cells during thymus regeneration. Histochem. Cell Biol. 123: 491-500.
19. Antonopoulos, C., M. Cumberbatch, R. J. Dearman, R. J. Daniel, I. Kimber, and R. W. Groves. 2001. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166: 3672-3677. (Pubitemid 32224888)
20. Mee, J. B., Y. Alam, and R. W. Groves. 2000. Human keratinocytes constitutively produce but do not process interleukin-18. Br. J. Dermatol. 143: 330-336.
21. Barbaroux, J. B., W. H. Kwan, J. P. Allam, N. Novak, T. Bieber, W. H. Fridman, R. Groves, and C. G. Mueller. 2006. Tumor necrosis factor-α- and IL-4-independent development of Langerhans cell-like dendritic cells from M-CSF-conditioned precursors. J. Invest. Dermatol. 126: 114-120.
22. Kim, N., P. R. Odgren, D. K. Kim, S. C. Marks, Jr., and Y. Choi. 2000. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc. Natl. Acad. Sci. USA 97: 10905-10910. (Pubitemid 30751252)
23. Kamath, A. T., S. Henri, F. Battye, D. F. Tough, and K. Shortman. 2002. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100: 1734-1741.
24. Jones, P. H., and F. M. Watt. 1993. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73: 713-724. (Pubitemid 23159010)
25. Zanet, J., S. Pibre, C. Jacquet, A. Ramirez, I. M. de Alboran, and A. Gandarillas. 2005. Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification. J. Cell Sci. 118: 1693-1704. (Pubitemid 40691897)
26. Czernielewski, J. M., and M. Demarchez. 1987. Further evidence for the selfreproducing capacity of Langerhans cells in human skin. J. Invest. Dermatol. 88: 17-20. (Pubitemid 17211832)
27. Brown, J. M., E. Corey, Z. D. Lee, L. D. True, T. J. Yun, M. Tondravi, and R. L. Vessella. 2001. Osteoprotegerin and rank ligand expression in prostate cancer. Urology 57: 611-616.
28. Takami, M., N. Takahashi, N. Udagawa, C. Miyaura, K. Suda, J. T. Woo, T. J. Martin, K. Nagai, and T. Suda. 2000. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in osteoblasts. Endocrinology 141: 4711-4719. (Pubitemid 32055151)
29. Takahashi, E., H. Mukohyama, K. Aoki, W. R. Duarte, U. H. Lerner, K. Ohya, K. Omura, and S. Kasugai. 2002. High extracellular calcium affects osteoclastogenesis in mouse bone marrow cell culture. J. Med. Dent. Sci. 49: 109-120. (Pubitemid 41151160)
30. +-promoted Ras inactivator as a possible regulator of RANKL shedding. J. Biol. Chem. 280: 41700-41706.
31. Bikle, D. D., D. Ng, C. L. Tu, Y. Oda, and Z. Xie. 2001. Calcium- and vitamin D-regulated keratinocyte differentiation. Mol. Cell. Endocrinol. 177: 161-171.
32. Mee, J. B., C. Antonopoulos, S. Poole, T. S. Kupper, and R. W. Groves. 2005. Counter-regulation of interleukin-1α(IL-1α) and IL-1 receptor antagonist in murine keratinocytes. J. Invest. Dermatol. 124: 1267-1274.
33. Holt, P. G., S. Haining, D. J. Nelson, and J. D. Sedgwick. 1994. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 153: 256-261.
34. Merad, M., M. G. Manz, H. Karsunky, A. Wagers, W. Peters, I. Charo, I. L. Weissman, J. G. Cyster, and E. G. Engleman. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3: 1135-1141. (Pubitemid 35469697)
35. Griffiths, C. E. M., R. J. Dearman, M. Cumberbatch, and I. Kimber. 2005. Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine 32: 67-70.
36. Lewiecki, E. M. 2006. RANK ligand inhibition with denosumab for the management of osteoporosis. Expert. Opin. Biol. Ther. 6: 1041-1050.
37. Kim, D., R. E. Mebius, J. D. MacMicking, S. Jung, T. Cupedo, Y. Castellanos, J. Rho, B. R. Wong, R. Josien, N. Kim, et al. 2000. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J. Exp. Med. 192: 1467-1478. (Pubitemid 30953884)
38. Hofbauer, L., S. Kluger, C. Kühne, C. Dunstan, A. Burchet, M. Schoppet, A. Zielke, and A. Heufelder. 2002. Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland. J. Cell. Biochem. 86: 642-650. (Pubitemid 34839966)
39. Van Poznak, C., S. S. Cross, M. Saggese, C. Hudis, K. S. Panageas, L. Norton, R. E. Coleman, and I. Holen. 2006. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours. J. Clin. Pathol. 59: 56-63. (Pubitemid 43076239)